Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Chugai Pharmaceutical Co., Ltd
  6. News
  7. Summary
    4519   JP3519400000

CHUGAI PHARMACEUTICAL CO., LTD

(4519)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Chugai Pharmaceutical : Personnel Changes

11/18/2021 | 03:12am EST

Personnel Changes

TOKYO, November 18, 2021 --Chugai Pharmaceutical Co., Ltd.(TOKYO: 4519) announced the following personnel changes, effective January 1, 2022.

[Details of Personnel Changes]

Executive Officers

Name

New Responsibilities

Current Responsibilities

Toshiaki Itagaki

Executive Vice President

Executive Vice President

CFO

CFO

Head of Finance Supervisory Div.

Head of Finance Supervisory Div.

Supervisory responsibility for

Supervisory responsibility for

Finance & Accounting,

Finance & Accounting,

Corporate Communication,

Corporate Communication,

Purchasing, Digital Transformation

Purchasing, Digital Strategy, IT

Solution

Hiroyuki

Vice President

Vice President

Matsumoto

Marketing & Sales Div.

Head of Kanto-Minami Regional

Management Office,

Marketing & Sales Div.

Satoko Shisai

Vice President

Vice President

Head of Digital Transformation Unit

Head of Digital & IT Supervisory

Division

Department Heads

Name

New Responsibilities

Current Responsibilities

Tetsuya

Head of Audit Dept.

Head of Internal Audit Group 1,

Kobayashi

Audit Dept.

Koma Oki

Head of Research Support Dept.,

Head of HR Planning Group,

Research Div.

Human Resources Management

Dept.

Yasufumi Ueda

Head of CMC Development Dept.,

Deputy Head of API Process

Pharmaceutical Technology Div.

Development Dept.,

Pharmaceutical Technology Div.

Toshimitsu Ikoma

Head of Kanto-Minami Regional

Head of Chugoku and Shikoku

Management Office,

Regional Management Office,

Marketing & Sales Div.

Marketing & Sales Div.

Department Heads (cont.)

Name

New Responsibilities

Current Responsibilities

Ryuu Kondo

Head of Chugoku and Shikoku

Head of Hokkaido and Tohoku

Regional Management Office,

Regional Management Office Kita-

Marketing & Sales Div.

Tohoku Branch,

Marketing & Sales Div.

Group Company

Name

New Responsibilities

Current Responsibilities

Hitomichi Goto

President of Chugai Business

Head of HR Management Group,

Solution Co., Ltd.

Human Resources Management

Dept.

###

2/ 2

Disclaimer

Chugai Pharmaceutical Co. Ltd. published this content on 18 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 November 2021 08:11:10 UTC.


ę Publicnow 2021
All news about CHUGAI PHARMACEUTICAL CO., LTD
01/21CHUGAI PHARMACEUTICAL : Actemra Approved for Additional Indication of SARS-CoV-2 Pneumonia..
PU
2021CHUGAI PHARMACEUTICAL CO., LTD. : Ex-dividend day for final dividend
FA
2021CHUGAI PHARMACEUTICAL : Signs Joint Research Agreement with NCC for Asian International Co..
PU
2021Launch of Chugai's New TV Commercial 'Protect the Ordinary Days People Cherish' Featuri..
AQ
2021CHUGAI PHARMACEUTICAL : Anti-CD20 Monoclonal Antibody Rituxan Approved for Additional Indi..
PU
2021CHUGAI PHARMACEUTICAL : Launch of Chugai's New TV Commercial “Protect the Ordinary D..
PU
2021Chugai Pharmaceutical Co., Ltd. - Notice of Board of Director's Resolution on Applicati..
AQ
2021Chugai Obtained Highest A-Rating by CDP in Two Categories and SBT Validation for Greenh..
AQ
2021Chugai Pharmaceutical Co. - Update on the Development of Oral COVID-19 Drug Candidate A..
AQ
2021Nikkei 225 Declines 1.8% on Central Bank Outlooks
MT
More news
Analyst Recommendations on CHUGAI PHARMACEUTICAL CO., LTD
More recommendations
Financials
Sales 2021 975 B 8 577 M 8 577 M
Net income 2021 292 B 2 569 M 2 569 M
Net cash 2021 461 B 4 056 M 4 056 M
P/E ratio 2021 20,7x
Yield 2021 1,87%
Capitalization 6 051 B 53 179 M 53 211 M
EV / Sales 2021 5,73x
EV / Sales 2022 5,37x
Nbr of Employees 7 555
Free-Float -
Chart CHUGAI PHARMACEUTICAL CO., LTD
Duration : Period :
Chugai Pharmaceutical Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHUGAI PHARMACEUTICAL CO., LTD
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 3 680,00 JPY
Average target price 4 823,85 JPY
Spread / Average Target 31,1%
EPS Revisions
Managers and Directors
Tatsuro Kosaka Manager-Pharmaceutical Business Strategy Office
Osamu Okuda Manager-Life Cycle Management II
Itagaki Toshiaki CFO, Manager-Information Technology & Accounting
Hisafumi Okabe Senior Executive Officer & Head-Research
Junichi Nezu Executive Officer, GM-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
CHUGAI PHARMACEUTICAL CO., LTD-1.47%53 179
JOHNSON & JOHNSON-3.40%434 036
ROCHE HOLDING AG-4.87%319 830
PFIZER, INC.-10.60%296 303
ABBVIE INC.-2.53%233 325
ELI LILLY AND COMPANY-11.98%220 356